Pfizer/Boehringer Spiriva Launched At 30% Discount To Advair For COPD
Executive Summary
Pfizer and Boehringer Ingelheim are launching the chronic obstructive pulmonary disease therapy Spiriva at a 30% discount to the average wholesale price of GlaxoSmithKline's Advair